BSE Live
Jan 23, 16:01Prev. Close
458.10
Open Price
458.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:48Prev. Close
458.00
Open Price
460.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
440.25 (137)
| Profit & Loss account of Thyrocare Technologies (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 394.59 | 367.42 | 326.32 | 288.79 | 225.61 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 394.59 | 367.42 | 326.32 | 288.79 | 225.61 | |
| Total Operating Revenues | 401.06 | 370.28 | 331.79 | 297.53 | 235.14 | |
| Other Income | 9.42 | 13.66 | 23.64 | 11.41 | 5.20 | |
| Total Revenue | 410.48 | 383.94 | 355.43 | 308.94 | 240.34 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 110.17 | 103.25 | 88.07 | 75.75 | 59.66 | |
| Purchase Of Stock-In Trade | 2.25 | 2.33 | 2.41 | 2.56 | 6.64 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -0.08 | -0.26 | 0.37 | -0.36 | 0.68 | |
| Employee Benefit Expenses | 45.75 | 40.51 | 32.49 | 30.22 | 24.29 | |
| Finance Costs | 1.32 | 0.47 | 0.40 | 0.26 | 0.00 | |
| Depreciation And Amortisation Expenses | 19.54 | 14.47 | 12.08 | 11.69 | 11.35 | |
| Other Expenses | 75.20 | 76.31 | 69.45 | 74.64 | 49.26 | |
| Total Expenses | 254.15 | 237.08 | 205.27 | 194.76 | 151.88 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 156.33 | 146.86 | 150.16 | 114.18 | 88.46 | |
| Exceptional Items | -44.33 | 0.00 | -2.19 | -27.43 | 0.30 | |
| Profit/Loss Before Tax | 112.00 | 146.86 | 147.96 | 86.74 | 88.76 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 42.74 | 52.90 | 52.37 | 40.30 | 32.10 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -10.06 | -1.27 | -0.44 | -0.23 | -1.69 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | -0.41 | |
| Total Tax Expenses | 32.68 | 51.63 | 51.93 | 40.08 | 30.00 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 79.32 | 95.23 | 96.04 | 46.67 | 58.75 | |
| Profit/Loss From Continuing Operations | 79.32 | 95.23 | 96.04 | 46.67 | 58.75 | |
| Profit/Loss For The Period | 79.32 | 95.23 | 96.04 | 46.67 | 58.75 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 15.02 | 17.84 | 17.91 | 8.69 | 11.42 | |
| Diluted EPS (Rs.) | 14.99 | 17.80 | 17.85 | 8.69 | 11.41 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 2.14 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 57.52 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 132.00 | 26.87 | 53.72 | 40.29 | 51.33 | |
| Tax On Dividend | 27.03 | 5.53 | 11.01 | 8.20 | 10.53 | |
| Equity Dividend Rate (%) | 50.00 | 200.00 | 100.00 | 100.00 | 100.00 |
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
24.10.2025
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
24.07.2025
Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss